Sort
46,585 grants matching “heart failure”
Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.
$753,094Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2025 · AI
Advanced Heart Failure: Epidemiology and Outcomes
$753,041Shannon Marie Dunlay · Mayo Clinic Rochester · R01 · FY2022 · HL
Direct detection of nanoparticles in blood: a novel diagnostic for Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
$753,015Franklin Monzon · Spectradyne, Llc · R44 · FY2015 · EB
Modifier Genes in Heart Failure
$752,941Duke University · R01 · FY2001 · HL
Pragmatic collaborative care for cardiac inpatients with depression or anxiety
$752,873Jeff C Huffman · Massachusetts General Hospital · R01 · FY2018 · HL
Longitudinal Study of Dialysis
$752,768Rulan S Parekh · Johns Hopkins University · R01 · FY2009 · DK
Liquid biopsies to evaluate the effect of a ketogenic diet on molecular circuitries associated with mild cognitive impairment
$752,765Gagan Deep · Wake Forest University Health Sciences · R01 · FY2025 · AG
Late Sodium Current Blockade in High-Risk ICD Patients - DCC
$752,744Arthur J. Moss · University Of Rochester · U01 · FY2012 · HL
Pragmatic collaborative care for cardiac inpatients with depression or anxiety
$752,742Jeff C Huffman · Massachusetts General Hospital · R01 · FY2020 · HL
RE-ENERGIZE FONTAN - RandomizEd Exercise INtERvention desiGned to MaximIZE Fitness in Pediatric FONTAN patients
$752,734Elif Seda Selamet Tierney · Stanford University · R61 · FY2020 · HL
Positive Airway Pressure For The Treatment Of The Obstructive Sleep Apnea Syndrome In Children With Down Syndrome
$752,717Ignacio Esteban Tapia · Children'S Hosp Of Philadelphia · R61 · FY2019 · HL
Translational studies in Heart Failure Gene Therapy
$752,665Charles R Bridges · University Of Pennsylvania · R01 · FY2007 · HL
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
$752,579Vassilios James Bezzerides · Boston Children'S Hospital · R01 · FY2025 · HL
Portable pneumatic driver for counterpulsation therapy
$752,574Paul A Spence · Scr, Inc. · R44 · FY2009 · HL
Chronic Kidney Disease Prognosis Consortium
$752,562Josef Coresh · Johns Hopkins University · R01 · FY2018 · DK
Effects of SGLT2 Inhibition on Coronary Flow Reserve and Other Key Indices Relevant to Type 2 Myocardial Infarction Risk among Women with HIV
$752,558Markella V. Zanni · Massachusetts General Hospital · R01 · FY2025 · HL
Protein Misfolding Diseases and Oxido-Reductive Pathways
$752,500Ivor J Benjamin · University Of Utah · DP1 · FY2009 · OD
Maglev LVAD with expandable stented inlet and anti-thrombotic coating to improve hemocompatibility
$752,493O. H. Frazier · Texas Heart Institute · R01 · FY2023 · HL
Elucidation of the Influence of Sleep Apnea on Risk of Atrial Fibrillation
$752,442Reena Mehra · Case Western Reserve University · R01 · FY2012 · HL
Myocardial Tissue Characterization with MR Relaxometry in Heart Failure
$752,436Reza Nezafat · Beth Israel Deaconess Medical Center · R01 · FY2019 · HL
Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy
$752,426Dean J Burkin · Strykagen Corporation · R42 · FY2021 · OD
The Chronic Rhinosinusitis (CRS) Problem and an AI Driven Personalized Medicine Solution
$752,420Vijay Ramakrishnan · Indiana University Indianapolis · R01 · FY2024 · AI
Lead Optimization of Novel Inhibitors of Tissue Non-specific Alkaline Phosphatase
$752,413Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · AG
Lead Optimization of Novel Inhibitors of Tissue Non-specific Alkaline Phosphatase
$752,413Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · AG
Novel Signaling Mechanisms and Molecular Targets in the Stressed Myocardium
$752,398Yibin Wang · University Of California Los Angeles · R01 · FY2010 · HL